chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Feels tired; Pains and aches in joints; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pains and aches in joints), HEADACHE (Headache), NAUSEA (Nausea) and FATIGUE (Feels tired) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ARTHRALGIA (Pains and aches in joints), HEADACHE (Headache) and NAUSEA (Nausea). On an unknown date, the patient experienced FATIGUE (Feels tired). At the time of the report, ARTHRALGIA (Pains and aches in joints) had resolved, HEADACHE (Headache) and NAUSEA (Nausea) had not resolved and FATIGUE (Feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided.  Concomitant medicines include Blood pressure medicine, Diabetes medicine, Nebulizer for Asthma; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Severe sharp pain in abdomen, diarrhea, nausea; lasted 48 hours before being transported to hospital via ambulance due to severity of pain
Area of vaccine administration red and sore to touch and without heat(according to PA notes) with red streak running from it.
trouble walking; it was concluded that I had a stroke and the vaccine was likely the main contributor.; the right side of my body was very weak and my balance was off.; the right side of my body was very weak and my balance was off.; This is a spontaneous report from a contactable consumer. A 37-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration, administered on the left arm, at the age of 37 years, on Apr2021 at a SINGLE DOSE for covid-19 immunisation. Medical history included brain tumor from an unknown date and unknown if ongoing. On 09Apr2021, the patient stated, "I am undergoing immunotherapy treatment for a brain tumor. My doctors recommended I take the vaccine 2 weeks following my most recent treatment (administered every 4 weeks). Several hours after receiving the vaccine, the right side of my body was very weak and my balance was off. These symptoms went away by the next morning. 5 days later they came back and progressed. Ultimately, I went to the emergency room having trouble walking, using my right arm and staying balanced. All tests (MRIs, ultrasound, CT scan, extensive bloodwork, and more) proved that there were no apparent causes. Ultimately, it was concluded that I had a stroke and the vaccine was likely the main contributor. I am 37, in shape, and eat extremely well."  The patient was hospitalized for the events. The patient underwent lab tests and procedures which included blood test: there were no apparent causes, computerised tomogram: there were no apparent causes, magnetic resonance imaging: there were no apparent causes, sars-cov-2 test: negative on 15Apr2021 and ultrasound scan: there were no apparent causes on an unspecified date. Therapeutic measures (Aspirin prescription, Castor, physical therapy) were taken as a result of the events. The outcome of the events was recovering.  Information about Batch/Lot number has been requested.
Patient was given 2nd dose of Moderna by employer, Health  on 1/25/21. She informed her PCP the 24 hours after receiving 2nd dose she developed right jaw pain,and shooting sensation.  She was seen by dentist with no cause found.  On 1/29/21 she saw a provider who placed her on an antibiotics for possible sinusitis due to facial/ear pain. Was seen by PCP on 2/5/21 and diagnosed with trigeminal neuralgia and started on gabapentin and referred to neurology.
Information has been received from a consumer concerning two of her friend's children who on an unknown date were vaccinated with MMR II and developed autism. The patients' final outcome was not reported. Attempts to verify the existence of identifiable patients have been unsuccessful. Upon internal review autism was considered to be another important medical event. This is one of two reports received from the same source. No further information is available.
Moderna isn't authorized as a booster for kids yet.  Informed by leaving a message on their phone.  the mother said the father is a Dr.
pt recv vax 10FEB97 & w/in 1wk exp muscle aches & scratchy throat;sx resolved w/o prescription med;
Therapy non-responder  This case was reported by a nurse and described a subject (age and gender unknown) who did not respond to immunization to hepatitis B vaccine recombinant (Engerix-B).  On unspecified dates, the subject received Energix-B. On an unspecified date before 12 May 2006, a hepatitis B surface antibody titer was negative. It was reported that the titers were taken from one to five months after the third dose of Engerix-B was received. No adverse events were reported.
Local rx. Erythema/induration approximately 5 x 3 cm. Painful. Treated with MEDROL dose pak/KEFLEX.
Patient reported mild rash on left arm, slight fever and severe body aches and pain. Reported blood pressure 197/129, heart rate 126 at doctors office and diagnosed as being in Atrial Fibrillation. Patient did not report adverse reaction to pharmacy until 09/29/2018.
12/9 Started with a red and swollen with much pain at the injection site. After a week fatigue, felt a shooting and radiating pain with tingles in the left side arm. This kept on having this issue since the shot up unto today(01/13) At 10:30 on 01/12 saw my doctor and determined after a physical that I need to keep taking care of this and if after a 10 days if issue persist, they may do test and labs at that time.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 17-DEC-2013 the patient was vaccinated with expired GARDASIL lot # H016960, .5 ml, intramuscular. No adverse effect was reported. The outcome of expired vaccine administered and no adverse effect is unknown. Additional information is not expected.
Information has been received from a physician, via a company representative, concerning a patient (age and gender not specified), who on an unspecified date was vaccinated with a dose of PEDVAXHIB (OMPC) (lot # not reported).  Subsequently the patient developed a localized reaction (details not provided).  At the time of this report, the outcome of the events was unknown.  Additional information has been requested.
Pt began to feel faint w/ flushing/sweating in observation area.  RNs were waived over by parents.  Pt transferred via w/c to observation bay.  NO loss of consciousness.  Dad at bedside.  BP 94/55, HR 51, RR 14 -- > 98/53, 60, 16.  Pt feeling much better.  Pt stable and released from the vaccination site.
pt began crying cont p/vax; mom gave APAP as directed; pt cont to cry & scream; MD ordered mom to ER for eval if crying does not stop; mom stated will do so if pt starts again but has quieted as of 408PM;
A big red patch on her left arm; Warm; Had a tiny bit of arm soreness / little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Had a tiny bit of arm soreness / little sore), RASH ERYTHEMATOUS (A big red patch on her left arm) and FEELING HOT (Warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Had a tiny bit of arm soreness / little sore). On 22-Feb-2021, the patient experienced RASH ERYTHEMATOUS (A big red patch on her left arm) and FEELING HOT (Warm). On 14-Feb-2021, PAIN IN EXTREMITY (Had a tiny bit of arm soreness / little sore) had resolved. At the time of the report, RASH ERYTHEMATOUS (A big red patch on her left arm) and FEELING HOT (Warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up was received on 25may2021,  no new information.
Vaccine squirted in the eyes of the patient; eye felt normal outside of the irritation; This spontaneous case was reported by a pharmacist and describes the occurrence of EYE IRRITATION (eye felt normal outside of the irritation) and ACCIDENTAL EXPOSURE TO PRODUCT (Vaccine squirted in the eyes of the patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EYE IRRITATION (eye felt normal outside of the irritation). On 21-Nov-2021, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (Vaccine squirted in the eyes of the patient). On 21-Nov-2021, ACCIDENTAL EXPOSURE TO PRODUCT (Vaccine squirted in the eyes of the patient) had resolved. At the time of the report, EYE IRRITATION (eye felt normal outside of the irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Mother called reporting that son began feeling ill a few hours after receiving vaccinations.  At 11:00PM had an elevated temp of 101 degrees Fahrenheit.  He has been taking Ibuprofen continuously every 6 hrs. for elevated temp and body aches.  Per mother, temperature is going up to 102 degrees today 2/4/2011.
Pruritic rash on left ear and behind both knees began about 6 hours after getting Tdap for a dirty knife wound.  Treated todya with Zyrtec.
booster; body aches; severe night sweats; nausea; High fever of 104 degrees, lower fever of around 102 degrees for 5 days; severe fatigue; . This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 19 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 24Nov2021 18:00 (Lot number: FJ8762) at the age of 19 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8729, Vaccine Administration Time: 15:00 PM), administration date: 17Apr2021, when the patient was 18 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0168, Vaccine Administration Time: 15:00 PM), administration date: 08May2021, when the patient was 18 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 24Nov2021 18:00, outcome "unknown", described as "booster"; PAIN (non-serious) with onset 24Nov2021, outcome "recovering", described as "body aches"; NIGHT SWEATS (non-serious) with onset 24Nov2021, outcome "recovering", described as "severe night sweats"; NAUSEA (non-serious) with onset 24Nov2021, outcome "recovering", described as "nausea"; PYREXIA (non-serious) with onset 24Nov2021, outcome "recovered" (29Nov2021), described as "High fever of 104 degrees, lower fever of around 102 degrees for 5 days"; FATIGUE (non-serious) with onset 24Nov2021, outcome "recovering", described as "severe fatigue". The events "body aches", "severe night sweats", "nausea", "high fever of 104 degrees, lower fever of around 102 degrees for 5 days" and "severe fatigue" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain, night sweats, nausea, pyrexia, fatigue.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown the patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), HEADACHE (Headaches) and NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo), HEADACHE (Headaches) and NAUSEA (Nausea). At the time of the report, VERTIGO (Vertigo), HEADACHE (Headaches) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided. No treatment information was mentioned.
Initial information received on 01-Mar-2019 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a male patient who experienced illness, while he received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE and while treated with PREVENAR 13. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking PREVENAR 13 dosage unknown (with an unknown batch number) for Immunisation. On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious illness (ill-defined disorder) (unknown latency) following the intake of PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) and DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE. (Other relevant tests included NO lab data). Final diagnosis was illness. It was not reported if the patient received a corrective treatment. The patient outcome was not reported. List of document held by sender: none.
Fever peaking at 101.4°F, chills, body aches, and headache.
people who got vaccine still got shingles / Suspected vaccination Failure; still got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: people who got vaccine still got shingles / Suspected vaccination Failure) (serious criteria GSK medically significant) and shingles (Verbatim: still got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 04-MAR-2023 This case was reported via interactive digital media. The reporter reported that he or she was on another group and most of the people (patients) who got the vaccine still got shingles. Cut sugar out of your diets. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Information has been received from a consumer concerning to her 19 year old daughter with sulfa and penicillin allergies who on 24-SEP-2009 was vaccinated with a first dose of GARDASIL (Lot # was not provided). Concomitant therapy included Generic LEXAPRO. On 24-SEP-2009 the patient experienced that her whole body was itching, her entire arm and lips went numb, her teeth hurt and she developed a headache. The patient has sought medical attention. At the time of this report, the patient recovered on 25-Sep-2009. Additional information has been requested.
Patient post vaccinations c/o feeling warm and lightheaded, patient vomited x1 with resolution of symptoms.  Patient was offered water and was continuously monitored.    HR 76 strong/regular 1306 All symptoms resolved
56 adults patients received doses after its expiration date Jul 13, 2022; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 004m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Caller mentioned that "the CDC had just approved extended expiration dates" and wanted to know if it was extended. When asked the caller stated that there were no remaining vials unused of that lot number and MI agent reminded the caller that no patients should receive doses from expired vials. Dose was administered after 30-day Use by Date or after manufacturer date of expiry. Vial did not undergo any temperature excursions.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-701125 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-701125:Master case
COVID- 19 pfizer - 2nd booster given after 3 months rather than the recommended 4 months between vaccines. No adverse effects noted, no treatment needed.
pain at the injection site; This is a spontaneous report from a contactable consumer. A 71-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number FF09262), via an unspecified route of administration on 28Jan2021 12:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient had pain at the injection site with the Covid-19 vaccine. It has been over 21 hours. Is due for the second one on 18Feb2021. The outcome of the event was not recovered.
Dizziness, disorientation,  very bad headache on the top of my head, confusion, problems with concentrating and comprehending, lightheaded, fatigue, sensitivity to light. I had a concussion 5-years ago from a car accident and recovered after one year. The symptoms of my concussion have returned within 30 minutes of receiving the Covid vaccine.
Received Covid injection at about 10th day of Covid infection. Had taken a dose of Augmentin for the Covid infection. Within a few days of injection noticed ringing in both ears. Received  auditory testing and ENT review within 2 weeks of the tinnitus starting. Took Flonase, Afrin, Sudafed for a few weeks, with not change in symptoms. Eight months later, I still have the tinnitus.
Patient complained of lightheadedness, blurry vision approximately 15 minutes post vaccination.  VS:  BP=130/82 , Pulse=72, O2 sat=99.  Drank two bottles during recovery, but refused fruit snacks or granola bar due to brittle diabetes and afraid of elevated blood sugar.  VS rechecked at 0958: BP=110/78, Pulse=68, and O2 sat=99%.  Released to go home.  Card with contact information given to call if further sxs occur.  Denied any other vaccines 1 month prior to first injection.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Epilepsy" (unspecified if ongoing); "Ulcerative colitis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Minocycline, reaction(s): "allergies Minocycline"; Cephalexin, reaction(s): "allergies cephalexin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: positive test with symptoms 7 days after finishing paxlovid and previous negative test; Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient started Paxlovid from 19May2023 to 24May2023 for treatment of COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
high pitched screaming, unconsolable crying for about 6 hrs; did not see pt; vax given @ hlth dept; prescribed APAP;
PT had no reactions post administration. About 36 hours after administration, the patient had a CVA. Pt experienced numbness in his left arm and shortly after proceed to have slurred speech and loss of balance and gait. Patient take to Emergency Room where he received the diagnosis. the patient was hospitalized. After several days, patient was discharge and was recovering.
approximately 8 days after the first shot right arm at injection site swelled up, got tight and hard, with a red rash that expanded over the next 4 four days...today is Monday and it has calmed down...not gone yet.
Husband reports patient had headache for 3 days 11/13 through 11/16 ; received above vaccines 11/16 and that evening she c/o low fever and general body aches and weakness.  11/18 she felt no better so husband called facility to report. All other s/s denied. 11/20 husband again called reporting that family has no primary care MD continues to have body aches( primarily her feet). PHN provided information regarding qualifying health clinics , offered to enter VAERS and instructed husband to bring her to urgent care if necessary. Upon husbands request information on drive through COVID testing provided